What is the Impact of Outreach Services on Medication Adherence for COPD Patients? A Systematic Review

References

• GOLD Global Initiative for Chronic Obstructive Lung Disease. 2019 Global Strategy for Prevention, Diagnosis and Management of COPD 2018. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed 10th January, 2019.
   Google Scholar
• RCPI, Royal, College, et al. COPD National Collaborative Pilot Report 2018.
   Google Scholar
• National Office of Clinical Audit. National Audit of Hospital Mortality Annual Report 2017 2018 [cited 15 Jan 2019]. Available from: http://s3-eu-west-1.amazonaws.com/noca-uploads/general/National_Audit_of_Hospital_Mortality_Annual_Report_2017_FINAL.pdf. .
   Google Scholar
• Irish Thoracic Society. Respiratory Health of the Nation – 2018 2018 [cited 12 Jan 2019]. Available from: https://irishthoracicsociety.com/wp-content/uploads/2018/12/RESP-Health-LATEST19.12.pdf.
   Google Scholar
• World Health Organisation (WHO). Chronic Obstructive Pulmonary Disease – factsheet. 2017 [cited 12 Jan 2019]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-. (copd) .
   Google Scholar
• Forum of International Respiratory Societies. The global impact of respiratory diseases. 2nd ed. 2017 [cited 16 Jan 2019]. Available from: http://www.firsnet.org/images/publications/The_Global_Impact_of_Respiratory_Disease.pdf .
   Google Scholar
• Wziątek-Nowak W, Gierczyński J, Dąbrowiecki P, et al. Socioeconomic effects of chronic obstructive pulmonary disease from the public payer’s perspective in Poland. In: Pokorski M, ed. Respirology. Cham: Springer International Publishing; 2016; p. 53–66.
   Google Scholar
• Løkke A, Hilberg O, Tønnesen P, et al. Health, social and economic consequences of chronic obstructive pulmonary disease (COPD): a controlled national study. Eur Respir J. 2012;40(Suppl 56):P995.
   Google Scholar
• World Health Organisation WHO. Adherence to long-term therapies – evidence for action 2003 [cited 14 Jan 2019]. Available from: http://apps.who.int/medicinedocs/en/d/Js4883e/. .
   Google Scholar
• Chakrabarti S. What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014;4(2):30–36. DOI:10.5498/wjp.v4.i2.30
   PubMedGoogle Scholar
• Gregoriano C, Henny-Reinalter S, Maier S, et al. Patients' adherence to chronic treatment in lung diseases: preliminary data from a randomized controlled trial. Eur Respir J. 2016;48(Suppl 60):PA1038. DOI:10.1183/13993003.congress-2016.PA1038
   Google Scholar
• Duarte-de-Araújo A, Teixeira P, Hespanhol V, et al. COPD: understanding patients' adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767–2773. DOI:10.2147/COPD.S160982
   PubMed Web of Science ®Google Scholar
• Blackstock FC, ZuWallack R, Nici L, et al. Why don't our patients with chronic obstructive pulmonary disease listen to us? The enigma of nonadherence. Ann Am Thorac Soc. 2016;13(3):317–323. DOI:10.1513/AnnalsATS.201509-600PS
   PubMed Web of Science ®Google Scholar
• Sulaiman I, Cushen B, Greene G, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(10):1333–1343. DOI:10.1164/rccm.201604-0733OC
   PubMed Web of Science ®Google Scholar
• Gutierrez-Valencia M, Izquierdo M, Malafarina V, et al. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: A retrospective study. Geriatr Gerontol Int. 2017;17(12):2354–2360. DOI:10.1111/ggi.13073
   PubMed Web of Science ®Google Scholar
• Sanduzzi A, Balbo P, Candoli P, et al. COPD: adherence to therapy. Multidiscip Respir Med. 2014;9(1):60–60. DOI:10.1186/2049-6958-9-60
   PubMedGoogle Scholar
• Zhong H, Ni X-J, Cui M, et al. Evaluation of pharmacist care for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Clin Pharm. 2014;36(6):1230–1240. DOI:10.1007/s11096-014-0024-9
   PubMed Web of Science ®Google Scholar
• Health Service Executive. COPD Outreach Programme: Model of Care 2011 [cited 10 Jan 2019]. Available from: https://www.hse.ie/eng/services/publications/clinical-strategy-and-programmes/copd-outreach-scheme-model-of-care-2011.pdf.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097 DOI:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Noyes J, Lewin S, et al. Chapter 5: extracting qualitative evidence. In: Noyes J, Booth A, Hannes K, editors. Supplementary guidance for inclusion of qualitative research in Cochrane systematic reviews of interventions. 2011.
   Google Scholar
• Bettany-Salticov JM, R. How to do a systematic literature review. A stepby-step guide. 2nd ed. New York: Open University Press; 2016.
   Google Scholar
• Moore Z. Meta-analysis in context . J Clin Nurs. 2012;21(19-20):2798–2807. V DOI:10.1111/j.1365-2702.2012.04122.x
   PubMed Web of Science ®Google Scholar
• Gough D, Oliver S, Thomas J. An introduction to systematic reviews. 2nd ed. London: Sage; 2017.
   Google Scholar
• Popay J, Roberts HM, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews. London: Institute for Health Research; 2006.
   Google Scholar
• Noyes J, Hannes K, Booth A, et al. Chapter QQ: Qualitative and implementation evidence and Cochrane reviews. In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration 2013.
   Google Scholar
• Glynn L. A critical appraisal tool for library and information research. Library Hi Tech. 2006;24(3):387–399. DOI:10.1108/07378830610692154
   Web of Science ®Google Scholar
• Alton S, Farndon L. The impact of community pharmacy-led medicines management support for people with COPD. Br J Commun Nurs. 2018;23(6):214–219. DOI:10.12968/bjcn.2018.23.6.214
   PubMedGoogle Scholar
• Takemura M, Mitsui K, Ido M, et al. Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients. Int J Chron Obstruct Pulmon Dis. 2013;8:239–244. DOI:10.2147/COPD.S44022
   PubMed Web of Science ®Google Scholar
• Damps-Konstańska I, Werachowska L, Krakowiak P, et al. Acceptance of home support and integrated care among advanced COPD patients who live outside large medical centers. Appl Nurs Res. 2016;31:60–64. DOI:10.1016/j.apnr.2015.12.003
   PubMed Web of Science ®Google Scholar
• Jarab AS, Alqudah SG, Khdour M, et al. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm. 2012;34(1):53–62. DOI:10.1007/s11096-011-9585-z
   PubMed Web of Science ®Google Scholar
• Khdour MR, Kidney JC, Smyth BM, et al. Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol. 2009;68(4):588–598. DOI:10.1111/j.1365-2125.2009.03493.x
   PubMed Web of Science ®Google Scholar
• Tommelein E, Mehuys E, Van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol. 2014;77(5):756–766. DOI:10.1111/bcp.12242
   PubMed Web of Science ®Google Scholar
• Wei L, Yang X, Li J, et al. Effect of pharmaceutical care on medication adherence and hospital admission in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled study. J Thorac Dis. 2014;6(6):656–662. DOI:10.3978/j.issn.2072-1439.2014.06.20
   PubMed Web of Science ®Google Scholar
• van Boven JFM, Stuurman-Bieze AGG, Hiddink EG, et al. Effects of targeting disease and medication management interventions towards patients with COPD. Curr Med Res Opin. 2016;32(2):229–239. DOI:10.1185/03007995.2015.1110129
   PubMed Web of Science ®Google Scholar
• Blakey JD, Bender BG, Dima AL, et al. Digital technologies and adherence in respiratory diseases: The road ahead. Eur Respir J. 2018;52(5):1801147. DOI:10.1183/13993003.01147-2018
   PubMed Web of Science ®Google Scholar
• ICGP Irish College of General Practitioners. Management of chronic obstructive pulmonary disease in general practice. Dublin: ICGP; 2009.
   Google Scholar
• Conn VS, Ruppar TM, Enriquez M, et al. Medication adherence interventions that target subjects with adherence problems: systematic review and meta-analysis. Res Social Adm Pharm: RSAP. 2016;12(2):218–246. DOI:10.1016/j.sapharm.2015.06.001
   PubMed Web of Science ®Google Scholar
• Mitsiki E, Kazanas K, Hatziapostolou P. Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study. Eur Respir J. 2015;46(suppl 59):PA3854.
   Google Scholar
• van Boven JF, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Res. 2014;15(1):66 DOI:10.1186/1465-9921-15-66
   PubMed Web of Science ®Google Scholar
• Cramm JM, Nieboer AP. Disease management: the need for a focus on broader self-management abilities and quality of life. Popul Health Manag. 2015;18(4):246–255. DOI:10.1089/pop.2014.0120
   PubMed Web of Science ®Google Scholar
• Emerson RW. Measuring change: pitfalls in research design. J Vis Impair Blind. 2016;110(4):288–290. DOI:10.1177/0145482X1611000412
   Web of Science ®Google Scholar